{
  "abstract": "Bullous pemphigoid is a severe autoimmune blistering disease, and Norwegian scabies is a rare comorbidity. However, conventional treatment methods, such as systemic corticosteroids, carry a high risk in the treatment of elderly patients. Herein, this rare comorbidity is described in an elderly patient. After an initial induction treatment with a low-to-moderate dose of corticosteroid, this patient achieved complete remission with a combination therapy of dupilumab (a monoclonal antibody targeting the interleukin-4/13 signaling pathway) and ivermectin. Therefore, the successful treatment of this rare case provides a promising strategy for reducing reliance on corticosteroids in high-risk populations.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Dermatology, The Third People’s Hospital of Longgang, Clinical Institute of Shantou University Medical College (The Third People’s Hospital of Longgang District Shenzhen), Shenzhen, China",
    "Department of Dermatology, Shenzhen People’s Hospital (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University), Shenzhen, China",
    "Department of Dermatology, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, China"
  ],
  "article_type": "case report",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Yanli Zhang"
    },
    {
      "affs": [
        1
      ],
      "name": "Yuting Liu"
    },
    {
      "affs": [
        0,
        2
      ],
      "name": "Hengan Yi"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/5e5egdaq27nw6.bib",
  "cited_by": 0,
  "doi": "10.4269/ajtmh.26-0186",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13615284/",
  "id": "5e5egdaq27nw6",
  "issns": [
    "0002-9637",
    "1476-1645"
  ],
  "landing_url": "https://doi.org/10.4269/ajtmh.26-0186",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Case Report"
    ],
    [
      "openalex",
      "2708|Autoimmune Bullous Skin Diseases"
    ]
  ],
  "openalex": "W7214057069",
  "pdf_url": null,
  "pmcid": "PMC13615284",
  "pmid": "42772271",
  "published": "2026-09-22",
  "publisher": "The American Society of Tropical Medicine and Hygiene",
  "ris": "https://research.draconitic.com/paper/5e5egdaq27nw6.ris",
  "sources": [
    {
      "first_seen": "2026-11-09T12:20:35Z",
      "native_id": "PMC13615284",
      "source": "pmc",
      "url": "https://doi.org/10.4269/ajtmh.26-0186"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2708|Autoimmune Bullous Skin Diseases",
      "subfield": "general"
    }
  ],
  "title": "Management of Bullous Pemphigoid and Norwegian Scabies with Dupilumab Plus Ivermectin",
  "title_text": "Management of Bullous Pemphigoid and Norwegian Scabies with Dupilumab Plus Ivermectin",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T12:20:35Z",
  "url": "https://research.draconitic.com/paper/5e5egdaq27nw6",
  "venue": "The American Journal of Tropical Medicine and Hygiene",
  "versions": []
}